FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Björn Carlsson

Research Profile

Chemicals & Drugs

Living Beings

Procedures

High Pressure Liquid Chromatography

Anatomy

Postmortem Changes

Concepts & Ideas

Co-author Network

Publications

TOP 3
L Karlsson; Anna-Lena Zackrisson; Johan Ahlner; F Bengtsson; Björn Carlsson; H Green; I Jakobsen Falk; Fredrik C Kugelberg
ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.
Svante Vikingsson; Curt Peterson; Sven Almer; Björn Carlsson; Martin Josefsson
Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use.
Louise Karlsson; Christoph Hiemke; Björn Carlsson; Martin Josefsson; Johan Ahlner; Finn Bengtsson; Ulrich Schmitt; Fredrik C Kugelberg
Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Björn Carlsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L Karlsson; Anna-Lena Zackrisson; Johan Ahlner; F Bengtsson; Björn Carlsson; H Green; I Jakobsen Falk; Fredrik C Kugelberg
ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.
International journal of legal medicine 2013;127(3):579-86.
2013: Svante Vikingsson; Curt Peterson; Sven Almer; Björn Carlsson; Martin Josefsson
Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use.
Journal of pharmaceutical and biomedical analysis 2013;75():145-52.
2011: Louise Karlsson; Christoph Hiemke; Björn Carlsson; Martin Josefsson; Johan Ahlner; Finn Bengtsson; Ulrich Schmitt; Fredrik C Kugelberg
Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.
Psychopharmacology 2011;215(2):367-77.
2011: Maria Kingbäck; Björn Carlsson; Johan Ahlner; Finn Bengtsson; Fredrik C Kugelberg
Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats.
Chirality 2011;23(2):172-7.
2010: Maria Kingbäck; Martin Josefsson; Louise Karlsson; Johan Ahlner; Finn Bengtsson; Fredrik C Kugelberg; Björn Carlsson
Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction.
Journal of pharmaceutical and biomedical analysis 2010;53(3):583-90.
2010: Louise Karlsson; Ulrich Schmitt; Martin Josefsson; Björn Carlsson; Johan Ahlner; Finn Bengtsson; Fredrik C Kugelberg; Christoph Hiemke
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(9):632-40.
2010: S Vikingsson; Björn Carlsson; Sven Almer; Curt Peterson
How should thiopurine treatment be monitored?--methodological aspects.
Nucleosides, nucleotides & nucleic acids 2010;29(4-6):278-83.
2009: Svante Vikingsson; Björn Carlsson; Sven H C Almer; Curt Peterson
Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?
Therapeutic drug monitoring 2009;31(3):345-50.
2009: Björn Carlsson; Anita Holmgren; Johan Ahlner; Finn Bengtsson
Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19.
Journal of analytical toxicology 2009;33(2):65-76.
2007: Margareta Reis; Maria D Chermá; Björn Carlsson; Finn Bengtsson
Therapeutic drug monitoring of escitalopram in an outpatient setting.
Therapeutic drug monitoring 2007;29(6):758-66.
2006: Fredrik C Kugelberg; Kanar Alkass; Maria Kingbäck; Björn Carlsson; Henrik Druid
Influence of blood loss on the pharmacokinetics of citalopram.
Forensic science international 2006;161(2-3):163-8.
2006: Fredrik C Kugelberg; Gustav Apelqvist; Björn Carlsson; Johan Ahlner; Finn Bengtsson
Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin.
Basic & clinical pharmacology & toxicology 2006;99(1):80-8.
2006: Margareta Reis; Fredrik C Kugelberg; Björn Carlsson; Martin Josefsson; Bertil Waldeck
[Stereochemistry and drug effects--a neglected field of knowledge].
Läkartidningen 2006;103(17):1305-6, 1309-11.
2005: Fredrik C Kugelberg; Maria Kingbäck; Björn Carlsson; Henrik Druid
Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.
Journal of analytical toxicology 2005;29(4):223-8.
2004: Fredrik C Kugelberg; Henrik Druid; Björn Carlsson; Johan Ahlner; Finn Bengtsson
Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats.
Journal of analytical toxicology 2004;28(8):631-7.
2004: Per Holmgren; Björn Carlsson; Anna-Lena Zackrisson; Bertil Lindblom; Marja-Liisa Dahl; Maria Gabriella Scordo; Henrik Druid; Johan Ahlner
Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19.
Journal of analytical toxicology 2004;28(2):94-104.
2003: Fredrik C Kugelberg; Björn Carlsson; Johan Ahlner; Finn Bengtsson
Stereoselective single-dose kinetics of citalopram and its metabolites in rats.
Chirality 2003;15(7):622-9.
2002: Margareta Reis; Gunilla Olsson; Björn Carlsson; Jöns Lundmark; Marja-Liisa Dahl; Jan Wålinder; Johan Ahlner; Finn Bengtsson
Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
Journal of clinical psychopharmacology 2002;22(4):406-13.
2001: Björn Carlsson; G Olsson; Margareta Reis; J Walinder; Conny Nordin; Jöns Lundmark; Maria Gabriella Scordo; Marja-Liisa Dahl; Finn Bengtsson; Johan Ahlner
Enantioselective analysis of citalopram and metabolites in adolescents.
Therapeutic drug monitoring 2001;23(6):658-64.
2001: Daniel Ohman; Björn Carlsson; Björn Norlander
On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma. Results compared with solid-phase extraction methodology.
Journal of chromatography. B, Biomedical sciences and applications 2001;753(2):365-73.
2001: Fredrik C Kugelberg; Gustav Apelqvist; Björn Carlsson; Johan Ahlner; Finn Bengtsson
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.
British journal of pharmacology 2001;132(8):1683-90.
2000: Gustav Apelqvist; Cecilia Wikell; Björn Carlsson; Stephan Hjorth; Peter B F Bergqvist; Johan Ahlner; Finn Bengtsson
Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy.
Clinical neuropharmacology 2000;23(6):304-17.
1999: Cecilia Wikell; Gustav Apelqvist; Björn Carlsson; Stephan Hjorth; Peter B F Bergqvist; Fredrik C Kugelberg; Johan Ahlner; Finn Bengtsson
Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
Clinical neuropharmacology 1999;22(6):327-36.
1999: Henrik Druid; Per Holmgren; Björn Carlsson; Johan Ahlner
Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results.
Forensic science international 1999;99(1):25-34.
1997: Björn Carlsson; Björn Norlander
Solid-phase extraction with end-capped C2 columns for the routine measurement of racemic citalopram and metabolites in plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;702(1-2):234-9.